30 March 2020
Advice from Professor Griffiths on Psoriasis & COVID-19
Professor Chris Griffiths addresses some FAQs about psoriasis, immunosuppressant medications and COVID-19.
The current situation with COVID-19 (coronavirus) has created a significant amount of uncertainty for us all. Now more than ever, access to clear and accurate information is vital to help us to make informed decisions about our own health and wellbeing. With that in mind, we're honoured to bring you information from a world-leading psoriasis expert, Professor Chris Griffiths (Professor of Dermatology at the University of Manchester and Honorary Consultant Dermatologist at Salford Royal NHS Foundation Trust).
In the video below, our Chief Executive, Helen McAteer, puts some of your most frequently asked questions about psoriasis and COVID-19 to Professor Griffiths.
Topics covered include:
- Whether taking an immunosuppressant medication makes you more likely to catch COVID-19;
- How you can find out whether or not you are classed as 'extremely vulnerable' to COVID-19, and what to do if you are;
- Whether or not people who are taking immunosuppressant medicines should be staying at home, even if they are a 'key worker';
- Whether or not you should attend your scheduled blood test appointments as normal if you're taking systemic or biologic drugs;
- Whether having a flare-up of psoriasis makes you more likely to catch COVID-19;
- Whether the advice changes depending on the type of systemic or biologic drug you are taking;
- What is being done to help better understand the interactions between COVID-19 and psoriasis? Information about PsoProtect - the new global psoriasis patient registry for outcomes, therapy and epidemiology of COVID-19 infection.
Please note that this information is correct as of 30th March 2020. For up to date information, or if you think you may have the symptoms of COVID-19, please follow the latest NHS advice.